SCHEMBL14563194

SCHEMBL14563194

Cc1ccc2oc(=O)n(Cc3cccc(-c4ncc(N5CCN(OC(=O)OC(C)(C)C)CC5)cn4)c3)c2n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNIK Q9UKE5 7/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ MIF P14174 5/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ MET P08581 1/20 0.32
▸ GPR119 Q8TDV5 1/20 0.32
▸ PIK3CD O00329 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ USP2 O75604 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ CD74 P04233 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2556083 0.89 MAPK1 (0.42) MAPK1MEN1KMT2AGPR119MAPT
SCHEMBL14563261 0.88 MEN1 (0.36) TNIKMIFMEN1KMT2APOLB
SCHEMBL2546963 0.84 BRD4 (0.43) MAPK1MEN1KMT2APOLBKDM4E
SCHEMBL2545825 0.82 USP2 (0.41) TNIKMAPK1MIFMEN1KMT2A
SCHEMBL3631784 0.80 GPR119 (0.38) MAPK1GPR119PIK3CD
SCHEMBL2545745 0.78 WNT3A (0.41) GPR119ALDH1A1LMNA
SCHEMBL2543313 0.78 MIF (0.47) TNIKMIFMEN1KMT2APOLB
SCHEMBL13039415 0.77 KMT2A (0.49) MAPK1MIFMEN1KMT2APOLB
SCHEMBL2542519 0.76 POLB (0.43) TNIKMIFMEN1KMT2APOLB
SCHEMBL2545811 0.75 POLB (0.41) TNIKMIFMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2150551-B1 2-OXO-3-BENZYL-BENZOXAZOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS AS MET KINASE INHIBITORS FOR THE TREATMENT OF TUMORS MERCK PATENT GMBH (DE) 2013-01-16 — — EP disclosed
Send feedback